1. Home
  2. CACI vs BMRN Comparison

CACI vs BMRN Comparison

Compare CACI & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CACI International Inc.

CACI

CACI International Inc.

N/A

Current Price

$673.38

Market Cap

10.9B

Sector

Technology

ML Signal

N/A

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

N/A

Current Price

$58.38

Market Cap

12.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CACI
BMRN
Founded
1962
1996
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
12.3B
IPO Year
2007
1999

Fundamental Metrics

Financial Performance
Metric
CACI
BMRN
Price
$673.38
$58.38
Analyst Decision
Strong Buy
Buy
Analyst Count
17
28
Target Price
★ $747.20
$91.56
AVG Volume (30 Days)
238.4K
★ 2.4M
Earning Date
10-21-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 8.24
N/A
EPS
★ 5.84
0.77
Revenue
★ $4,467,860,000.00
$1,313,646,000.00
Revenue This Year
$12.98
$21.77
Revenue Next Year
$6.64
$14.91
P/E Ratio
$114.80
★ $74.42
Revenue Growth
2.60
★ 17.62
52 Week Low
$434.70
$49.26
52 Week High
$683.50
$70.98

Technical Indicators

Market Signals
Indicator
CACI
BMRN
Relative Strength Index (RSI) 68.80 53.37
Support Level $596.39 $58.03
Resistance Level $683.45 $60.76
Average True Range (ATR) 19.63 1.53
MACD 7.00 0.57
Stochastic Oscillator 82.02 78.95

Price Performance

Historical Comparison
CACI
BMRN

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: